Somatic genetic variations in APC, KRAS, BRAF, and PIK3CA genes are the most frequent in CRC, leading to the activation of key WNT–β-catenin and MAPK signal transduction pathways, which subsequently promote cell proliferation and cancer progression (Fig 5A). The gene discussed is BRAF; the disease is cancer.